PE20040623A1 - Combinacion de antagonista de nmda con inhibidores de la acetilcolina esterasa - Google Patents

Combinacion de antagonista de nmda con inhibidores de la acetilcolina esterasa

Info

Publication number
PE20040623A1
PE20040623A1 PE2003000527A PE2003000527A PE20040623A1 PE 20040623 A1 PE20040623 A1 PE 20040623A1 PE 2003000527 A PE2003000527 A PE 2003000527A PE 2003000527 A PE2003000527 A PE 2003000527A PE 20040623 A1 PE20040623 A1 PE 20040623A1
Authority
PE
Peru
Prior art keywords
combination
acetylcholine esterase
nmda antagonist
esterase inhibitors
inhibitors
Prior art date
Application number
PE2003000527A
Other languages
English (en)
Spanish (es)
Inventor
Lars Lykke Thomsen
Anders Gersel Pedersen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28051666&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20040623(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of PE20040623A1 publication Critical patent/PE20040623A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PE2003000527A 2002-05-31 2003-05-29 Combinacion de antagonista de nmda con inhibidores de la acetilcolina esterasa PE20040623A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200200844 2002-05-31

Publications (1)

Publication Number Publication Date
PE20040623A1 true PE20040623A1 (es) 2004-09-11

Family

ID=28051666

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2003000527A PE20040623A1 (es) 2002-05-31 2003-05-29 Combinacion de antagonista de nmda con inhibidores de la acetilcolina esterasa

Country Status (9)

Country Link
KR (1) KR101016927B1 (ru)
CN (1) CN1655793A (ru)
AR (1) AR040121A1 (ru)
CA (1) CA2426492C (ru)
EA (1) EA007632B1 (ru)
IS (1) IS7558A (ru)
PE (1) PE20040623A1 (ru)
UA (1) UA82480C2 (ru)
ZA (1) ZA200409147B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA107653U (uk) 2012-10-01 2016-06-24 Общєство С Огранічєнной Отвєтствєнностью "Валєнта-Інтєллєкт" Композиція лікарських засобів для лікування та профілактики поведінкових, психічних та когнітивних розладів
CN105294450B (zh) * 2014-05-29 2024-05-17 广州喜鹊医药有限公司 具有神经保护作用的金刚烷胺硝酸酯化合物及其制备和医药应用
WO2018062941A1 (ko) * 2016-09-30 2018-04-05 주식회사 바이오파마티스 도네페질 또는 그의 약학적으로 허용 가능한 염 및 메만틴 또는 그의 약학적으로 허용 가능한 염을 함유하는 치매 및 인지기능 장애 예방 또는 치료용 약학 조성물 및 이의 제조방법
KR20210072569A (ko) 2019-12-09 2021-06-17 주식회사 종근당 도네페질 및 메만틴을 포함하는 복합 제제

Also Published As

Publication number Publication date
CN1655793A (zh) 2005-08-17
CA2426492A1 (en) 2003-09-16
UA82480C2 (ru) 2008-04-25
EA007632B1 (ru) 2006-12-29
AR040121A1 (es) 2005-03-16
ZA200409147B (en) 2006-06-28
KR101016927B1 (ko) 2011-02-28
KR20050024296A (ko) 2005-03-10
IS7558A (is) 2004-11-26
EA200401617A1 (ru) 2005-06-30
CA2426492C (en) 2006-10-03

Similar Documents

Publication Publication Date Title
DE60029799D1 (de) Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe
UY26482A1 (es) Bifenil sulfonamidas como antagonistas de receptores de angiotensina endotelina duales
CO4560552A1 (es) Antagonistas de receptores de taquicininas no peptidicos
AR037771A1 (es) Moleculas pequenas para el tratamiento del crecimiento celular anormal
CL2008003593A1 (es) Compuestos derivados de isoxazolo-piridazina; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de trastornos cognitivos como el alzheimer
DE69727158D1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
DOP2002000438A (es) Inhibidores de la dipetidil peptidasa beta-amino heterocíclica para el tratamiento o la prevención de la diabetes
GT199900203A (es) Composiciones de celecoxib.
UA89220C2 (ru) Способ лечения вич/спида путем приема без пищи или в условиях голодания твердого фармацевтического дозированного состава ингибитора вич-протеазы
CL2008003480A1 (es) Compuestos derivados de amino-pirimidina, con propiedades inmunomoduladoras y que actuan a traves de tlr7; proceso para preparar los compuestos; compuestos intermediarios; composicion y combinacion farmaceutica que comprende a uno de los compuestos; y uso de los compuestos en la preparacion de medicamentos
BRPI0513317A (pt) ciclosporinas para tratar doença de alzheimer
NO20071823L (no) Testosterongeler omfattende polypropylenglykol som gjennomtrengningsforsterker
MA28909B1 (fr) Quinazolines utiles en tant que modulateurs de canaux ioniques
AR052071A1 (es) Procedimientos para modular las actividades del receptor nicotinico alfa 7 de acetilcolina
PE20120324A1 (es) Combinacion que comprende (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y donezepilo como moduladora de trastornos cognitivos
PA8579801A1 (es) Composiciones farmaceuticas de farmacos semiordenados y polimeros
AR056971A1 (es) COMPOSICIONES AZEOTRoPICAS QUE COMPRENDEN 1,1,3,3,3-PENTAFLUOROPROPENO Y FLUORURO DE HIDRoGENO Y USOS DE LAS MISMAS
GB0216001D0 (en) Process and composition
ES2174921T3 (es) Inhibidores de la proteasa del vih.
ATE253939T1 (de) Pharmazeutische zusammensetzung enthaltend einen squalenepoxidasehemmer und einen makrolid- immunomodulator
PE20040623A1 (es) Combinacion de antagonista de nmda con inhibidores de la acetilcolina esterasa
AR029155A1 (es) Combinacion y uso de la misma en la fabricacion de un medicamento util para tratar afecciones cardiovasculares
SV2008002856A (es) 2-amino-7, 8-dihidro-6h-pirido [4,3-d] pirimidina-5-onas
BRPI0415281A (pt) antagonistas de receptor de acetilcolina muscarìnico
MX2022005388A (es) Compuestos de pirrolidina y piperidina.

Legal Events

Date Code Title Description
FC Refusal